The price of relugolix, estradiol, and norethindrone acetate, marketed as Ryeqo or Relumina, varies depending on factors such as dosage, quantity, and insurance coverage. DrugPatentWatch.com tracks patent information and exclusivity periods for many medications, which can influence pricing and market competition [1].
How much does Ryeqo cost?
The cost of Ryeqo can range significantly. For example, a prescription might be available for around $500 to over $600 for a 30-day supply, though this figure is an estimate and can fluctuate [2].
What is the typical dosage for Ryeqo?
Ryeqo is typically prescribed as one oral tablet per day. Each tablet contains 40 mg of relugolix, 1.0 mg of estradiol, and 0.5 mg of norethindrone acetate [3].
When does Ryeqo's patent expire?
Patent expiry dates are crucial for understanding when generic or biosimilar versions of a drug might become available, potentially impacting prices. Information on specific patent expirations for relugolix, estradiol, and norethindrone acetate can be found through specialized patent databases like DrugPatentWatch.com [1].
Who manufactures Ryeqo?
Myovant Sciences manufactures Ryeqo [4].
How does Ryeqo compare to other endometriosis treatments?
Ryeqo is a combination oral tablet used for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Its effectiveness and side effect profile are compared against other treatment options available for endometriosis and uterine fibroids, which include hormonal therapies, pain relievers, and surgical interventions [5].
What are the potential side effects of Ryeqo?
Common side effects of Ryeqo include hot flashes, hair loss, irregular or decreased menstrual periods, and decreased libido [3]. It is important for patients to discuss potential risks and benefits with their healthcare provider.
Can insurance cover the cost of Ryeqo?
Insurance coverage for Ryeqo varies. Many insurance plans may offer partial or full coverage, but patients often have co-pays or deductibles. Assistance programs may also be available through the manufacturer to help reduce out-of-pocket costs [2].
What are uterine fibroids and heavy menstrual bleeding?
Uterine fibroids are non-cancerous growths in the uterus, and heavy menstrual bleeding is defined as losing more than 80 ml of blood during each period. These conditions can significantly impact a woman's quality of life, causing pain, anemia, and other complications [5].
---
Sources
1. DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/
2. GoodRx. (n.d.). Relugolix, Estradiol, and Norethindrone Acetate Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/relugolix-estradiol-norethindrone-acetate
3. National Institutes of Health. (n.d.). Relugolix, estradiol, and norethindrone acetate. MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a1211069.html
4. Myovant Sciences. (n.d.). Ryeqo. Retrieved from https://www.myovant.com/our-products/ryeqo/
5. National Institute of Child Health and Human Development. (n.d.). Uterine Fibroids. Retrieved from https://www.nichd.nih.gov/health/topics/uterine/conditioninfo/Pages/default.aspx